ClearPoint Neuro Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ClearPoint Neuro, Inc. (CLPT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents20.1023.1427.6254.1020.105.703.10
Short-Term Investments0.000.009.870.000.000.000.00
Cash & Short-Term Investments20.1023.1437.4954.1020.105.703.10
Accounts Receivable4.713.942.672.341.881.091.23
Inventory6.867.919.304.943.243.242.11
Other Current Assets1.681.181.720.510.240.000.00
Total Current Assets33.3636.1751.1861.8925.4610.386.65
Non-Current Assets
Property, Plant & Equipment (Net)5.094.952.702.783.060.820.38
Intangible Assets0.481.041.030.270.350.000.00
Other Non-Current Assets0.250.500.580.640.650.720.82
Total Non-Current Assets5.836.494.313.694.061.541.20
Total Assets39.1942.6655.4965.5829.5211.937.86
Current Liabilities
Accounts Payable1.340.390.270.960.302.700.89
Short-Term Debt0.560.000.000.000.000.000.00
Accrued Liabilities1.454.002.070.541.940.000.00
Deferred Revenue2.122.611.070.680.560.000.00
Other Current Liabilities6.342.952.822.601.600.000.00
Total Current Liabilities10.357.436.794.753.203.831.87
Non-Current Liabilities
Long-Term Debt3.019.959.8911.7821.280.283.48
Other Non-Current Liabilities0.003.150.000.000.000.000.00
Total Non-Current Liabilities3.4514.0611.8212.0423.941.444.48
Total Liabilities13.8021.4918.6016.7927.145.276.35
Stockholders' Equity
Common Stock0.280.250.250.240.170.000.00
Retained Earnings-191.37-172.46-150.37-133.93-119.52-112.74-107.20
Additional Paid-in Capital216.48193.38187.01182.48121.73117.17108.60
Shares Outstanding27.6224.6524.5823.670.000.000.00
Total Stockholders' Equity25.3921.1736.8948.792.384.591.51
Total Liabilities & Equity39.1942.6655.4965.5829.5211.937.86